Skip to product information
1 of 1

Merck Animal Health

Circumvent PCV-M G2-100 ml

Circumvent PCV-M G2-100 ml

Regular price $59.95 USD
Regular price Sale price $59.95 USD
Sale Sold out

Size: 100 ml

Swine vaccine for use in healthy swine as an aid in the prevention of viremia, as an aid in the reduction of virus shedding, as an aid in the reduction of lymphoid infection caused by Porcine Circovirus Type 2 (PCV2), and as an aid in the reduction of lung lesions due to Mycoplasma hyopneumoniae. Demonstrated PCV2 efficacy for at least 20 weeks following completion of vaccination.

Circumvent PCV M G2 is the reliable 1-dose RTU combo vaccine for PCV2 and mycoplasmal pneumonia, making it easier than ever to vaccinate for each disease. Even better, this next-generation vaccine can be used on young pigs when they're easier to handle. Start your pigs off right and improve your bottom line from the very beginning with Circumvent PCV-M G2.

Dosage: Option 1 - single 2 ml dose IM for pigs 3 weeks of age or older; Option 2 - 1 ml IM for pigs as early as 3 days of age, repeat in 3 weeks. 21-day slaughter withdrawal.

Manufacturer and/or Label Information

MERCK ANIMAL HEALTH
Intervet Inc.
2 GIRALDA FARMS, MADISON, NJ, 07940
Customer Service: 800-521-5767
Order Desk: 800-648-2118
Technical Service (Companion Animal): 800-224-5318
Technical Service (Livestock): 800-211-3573
Fax: 973-937-5557
Website: www.merck-animal-health-usa.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
Circumvent® PCV-M G2

Intervet/Merck Animal Health

Porcine Circovirus Vaccine, Type 2, Killed Baculovirus Vector

Mycoplasma Hyopneumoniae Bacterin

For use in healthy swine as an aid in the prevention of viremia, aid in the reduction of virus shedding and aid in the reduction of lymphoid infection caused by porcine circovirus type 2 (PCV 2), and as an aid in the reduction of lung lesions due to Mycoplasma hyopneumoniae. PCV 2 efficacy for at least 20 weeks following completion of vaccination has been demonstrated.

ADMINISTRATION and DOSAGE OPTIONS: Shake well. Warm the vaccine to room temperature immediately prior to administration. Use aseptic technique. OPTION 1: Vaccinate pigs intramuscularly at 3 weeks of age or older with a single 2 mL dose OPTION 2: Vaccinate pigs intramuscularly as early as 3 days of age with a 1 mL dose followed by a second 1 mL dose 3 weeks later.

CAUTIONS: Store at 2°-7°C (35°-45°F). Do not freeze. Use entire contents when first opened; do not save partial contents. Burn the container and all unused product. Use only in healthy swine. Do not vaccinate within 21 days before slaughter. The vaccine may induce significant localized adverse reactions, particularly following booster vaccination. Localized reactions resolve 1-35 days following vaccination. If allergic reaction occurs, treat with epinephrine. Caution should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. Contact a physician immediately.

PRESERVATIVES: Gentamicin and thimerosal.

FOR ANIMAL USE ONLY

Intervet Inc., Merck Animal Health, division of Intervet Inc., Omaha, Nebraska 68103 USA

U.S. Vet Lic. No. 165A

1 800 521-5767

For patent information: http://www.merck.com/product/patent/home.html





Code



100 mL

Option 1: 50 Doses-2 mL

Option 2: 100 Doses-1 mL

121365

148810-03

500 mL

Option 1: 250 Doses-2 mL

Option 2: 500 Doses-1 mL

124428

154119-03

CPN: 1047511.1
COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Dimensions

Care information

View full details